DOXOrubicin HCl 2 mg/ML Injectable Solution
RxNorm 1191138
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1191138 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: DOXOrubicin HCl 2 mg/ML Injectable Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
Doxorubicin hydrochloride 2 mg/ML Injectable Solution
(Atom ID: 12345122)
Prescribable Name (PSN):
DOXOrubicin HCl 2 mg/ML Injectable Solution
(Atom ID: 8213071)
Tall Man Lettering Synonym (TMSY):
DOXOrubicin hydrochloride 2 mg/ML Injectable Solution
(Atom ID: 12377292)
Designated preferred name (PT):
Doxorubicin hydrochloride 2 mg/mL solution for infusion
(Atom ID: 10801791)
Designated preferred name (PT):
Doxorubicin hydrochloride 2 mg/mL solution for injection
(Atom ID: 10801792)
Full form of descriptor (FN):
Product containing precisely doxorubicin hydrochloride 2 mg/1 mL conventional release solution for infusion (clinical drug)
(Atom ID: 10818805)
Full form of descriptor (FN):
Product containing precisely doxorubicin hydrochloride 2 mg/1 mL conventional release solution for injection (clinical drug)
(Atom ID: 10818806)
Patient Education
Doxorubicin
Doxorubicin is used in combination with other medications to treat certain types of bladder, breast, lung, stomach, and ovarian cancer; Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (cancer that begins in the cells of the immune system); and certain types of leukemia (cancer of the white blood cells), including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML, ANLL). Doxorubicin is also used alone and in combination with other medications to treat certain types of thyroid cancer and certain types of soft tissue or bone sarcomas (cancer that forms in muscles and bones). It is also used to treat neuroblastoma (a cancer that begins in nerve cells and occurs mainly in children) and Wilms' tumor (a type of kidney cancer that occurs in children). Doxorubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.
[Learn More]
Cancer Chemotherapy
Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.
You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.
Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).
NIH: National Cancer Institute
[Learn More]
* Please review the disclaimer below.
